Please Scroll Down to See Forums Below 
keepnitreal
New member
Im no fitness guru but honestly man just a simple clean diet will EASILY get you down a few bf%.. If ur starting at 20%
Sent from my SGH-I896 using EliteFitness
Best oral for cutting fat?
- Thread starter njguy1
- Start date
Im no fitness guru but honestly man just a simple clean diet will EASILY get you down a few bf%.. If ur starting at 20%
Sent from my SGH-I896 using EliteFitness
I can tell you that you should start your own thread!
thats the second thread he's done that in... consider this a friendly warning... if you do it again then your getting a timeout... read the rules!
saxon369
New member
Hey NJ I don't post a lot but wanted to say that I've been following the IF diet. That's 8 hrs eating and 16 hrs fasting then 8 on and 16 off again. It's a little rough at first to get used to but man it works better and faster than anything I've tried before. And still let's you hang on to your muscle if done right. But I agree with Dylan bro, I'd hold off on aas for now. Good luck bro!! 
patternsco
New member
I think the point dyaln etc is trying to make mate is that the purpose of aas is not to cut fat. if thats the case and you dont feel you can achieve the physical form you want, then (and i dont like to suggest this) a cutting drug wold be better. From what you said and i mean no disrespect, you need to learn more about aas and train for longer imo. if the doc reccomnends lipo then do it.
isteroids point is that of the lot those 2 prob are known for better fat loss results, alhtough this tend to be visceral fat and not subcut which you talk of. Theres a few studies suggesting fat loss, but tbh the majority will tell you its either water weight or the increase in muscle mass/strength, not direct fat burning. although you dropped a lot of weight you should train hard for couple years and reach your full potential first naturally before considering aas.
If i were you, i'd start training to add muscle, and do the lipo. i dropped 36kg and have put on approx 6-7lg of muscle in 18months. it can be done and aas isnt going to work unless your diet and training are nailed anyway, and fom the sounds of it your body is no condition for aas.
good luck bud
isteroids point is that of the lot those 2 prob are known for better fat loss results, alhtough this tend to be visceral fat and not subcut which you talk of. Theres a few studies suggesting fat loss, but tbh the majority will tell you its either water weight or the increase in muscle mass/strength, not direct fat burning. although you dropped a lot of weight you should train hard for couple years and reach your full potential first naturally before considering aas.
If i were you, i'd start training to add muscle, and do the lipo. i dropped 36kg and have put on approx 6-7lg of muscle in 18months. it can be done and aas isnt going to work unless your diet and training are nailed anyway, and fom the sounds of it your body is no condition for aas.
good luck bud
patternsco
New member
i think the point he's trying to make is he has loose skin/fat. if so getting bigger may actually help, but id defo do the lipo first and seriously be training or 2 years to understand it. very different lifestyle from dieting.
Interesting read:
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808-4124, USA.
OBJECTIVE: To compare the effects of testosterone enanthate (TE), anabolic steroid (AS) or placebo (PL) on regional fat distribution and health risk factors in obese middle-aged men undergoing weight loss by dietary means.
DESIGN: Randomized, double-blind, placebo-controlled clinical trial, carried out for 9 months with primary assessments at 3 month intervals. Due to adverse blood lipid changes, the AS group was switched from oral oxandrolone (ASOX) to parenteral nandrolone decaoate (ASND) after the 3 month assessment point. SUBJECTS: Thirty healthy, obese men, aged 40-60 years, with serum testosterone (T) levels in the low-normal range (2-5 ng/mL).
MAIN OUTCOME MEASURES: Abdominal fat distribution and thigh muscle volume by CT scan, body composition by dual energy X-ray absorptiometry (DEXA), insulin sensitivity by the Minimal Model method, blood lipids, blood chemistry, blood pressure, thyroid hormones and urological parameters.
RESULTS: After 3 months, there was a significantly greater decrease in subcutaneous (SQ) abdominal fat in the ASOX group compared to the TE and PL groups although body weight changes did not differ by treatment group. There was also a tendency for the ASOX group to exhibit greater losses in visceral fat, and the absolute level of visceral fat in this group was significantly lower at 3 months than in the TE and PL groups. There were significant main effects of treatment at 3 months on serum T and free T (increased in the TE group and decreased in the ASOX group) and on thyroid hormone parameters (T4 and T3 resin uptake significantly decreased in the ASOX group compared with the other two groups). There was a significant decrease in HDL-C, and increase in LDL-C in the ASOX group, which led to their being switched to the parenteral nandrolone decanoate (ASND) after 3 months. ASND had opposite effects on visceral fat from ASOX, producing a significant increase from 3 to 9 months while continuing to decrease SQ abdominal fat. ASND treatment also decreased thigh muscle area, while ASOX treatment increased high muscle. ASND reversed the effects of ASOX on lipoproteins and thyroid hormones. The previously reported effect of T to decrease visceral fat was not observed, in fact, visceral fat in the TE group increased slightly from 3 to 9 months, although SQ fat continued to decrease. Neither TE nor AS treatment resulted in any change in urologic parameters.
CONCLUSIONS: Oral oxandrolone decreased SQ abdominal fat more than TE or weight loss alone and also tended to produce favorable changes in visceral fat. TE and ASND injections given every 2 weeks had similar effects to weight loss alone on regional body fat. Most of the beneficial effects observed on metabolic and cardiovascular risk factors were due to weight loss per se. These results suggest that SQ and visceral abdominal fat can be independently modulated by androgens and that at least some anabolic steroids are capable of influencing abdominal fat.
Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808-4124, USA.
OBJECTIVE: To compare the effects of testosterone enanthate (TE), anabolic steroid (AS) or placebo (PL) on regional fat distribution and health risk factors in obese middle-aged men undergoing weight loss by dietary means.
DESIGN: Randomized, double-blind, placebo-controlled clinical trial, carried out for 9 months with primary assessments at 3 month intervals. Due to adverse blood lipid changes, the AS group was switched from oral oxandrolone (ASOX) to parenteral nandrolone decaoate (ASND) after the 3 month assessment point. SUBJECTS: Thirty healthy, obese men, aged 40-60 years, with serum testosterone (T) levels in the low-normal range (2-5 ng/mL).
MAIN OUTCOME MEASURES: Abdominal fat distribution and thigh muscle volume by CT scan, body composition by dual energy X-ray absorptiometry (DEXA), insulin sensitivity by the Minimal Model method, blood lipids, blood chemistry, blood pressure, thyroid hormones and urological parameters.
RESULTS: After 3 months, there was a significantly greater decrease in subcutaneous (SQ) abdominal fat in the ASOX group compared to the TE and PL groups although body weight changes did not differ by treatment group. There was also a tendency for the ASOX group to exhibit greater losses in visceral fat, and the absolute level of visceral fat in this group was significantly lower at 3 months than in the TE and PL groups. There were significant main effects of treatment at 3 months on serum T and free T (increased in the TE group and decreased in the ASOX group) and on thyroid hormone parameters (T4 and T3 resin uptake significantly decreased in the ASOX group compared with the other two groups). There was a significant decrease in HDL-C, and increase in LDL-C in the ASOX group, which led to their being switched to the parenteral nandrolone decanoate (ASND) after 3 months. ASND had opposite effects on visceral fat from ASOX, producing a significant increase from 3 to 9 months while continuing to decrease SQ abdominal fat. ASND treatment also decreased thigh muscle area, while ASOX treatment increased high muscle. ASND reversed the effects of ASOX on lipoproteins and thyroid hormones. The previously reported effect of T to decrease visceral fat was not observed, in fact, visceral fat in the TE group increased slightly from 3 to 9 months, although SQ fat continued to decrease. Neither TE nor AS treatment resulted in any change in urologic parameters.
CONCLUSIONS: Oral oxandrolone decreased SQ abdominal fat more than TE or weight loss alone and also tended to produce favorable changes in visceral fat. TE and ASND injections given every 2 weeks had similar effects to weight loss alone on regional body fat. Most of the beneficial effects observed on metabolic and cardiovascular risk factors were due to weight loss per se. These results suggest that SQ and visceral abdominal fat can be independently modulated by androgens and that at least some anabolic steroids are capable of influencing abdominal fat.
